Oregon Health and Science University, Psychiatry, Portland, OR 97239, USA.
Acad Psychiatry. 2010 Mar-Apr;34(2):102-8. doi: 10.1176/appi.ap.34.2.102.
Sales visits, or detailing, by pharmaceutical industry representatives at academic institutions has been increasingly criticized. The authors surveyed psychiatric residents and faculty members on their views and interactions with representatives of the pharmaceutical industry.
In 2007, a 46-item online survey measuring attitudes toward and interactions with pharmaceutical industry representatives was sent to 49 faculty psychiatrists and 40 psychiatric trainees (residents and fellows) at a Northwest academic medical center.
Sixty-five percent (N=58) of surveys were completed. Two-thirds of respondents did not agree that pharmaceutical representatives have an important teaching role. Only 24% of faculty and 18% of trainees agreed that pharmaceutical representatives provide useful and accurate information on new drugs. Forty-one percent of faculty and 53% of trainees agreed that pharmaceutical representatives should be restricted from making presentations on campus. Trainees were less likely than faculty to agree that they would maintain contact with representatives if no gifts or food were distributed. Nevertheless, most respondents endorsed that pharmaceutical companies supported important conferences, and more than 90% had attended an industry-sponsored event in the previous year. In open-ended questioning, respondents revealed worries that bans would undermine the ability to secure national speakers and to support other activities that residents valued.
Faculty and psychiatric residents and fellows do not view pharmaceutical representatives as having an important teaching role and mistrust the information they offer but believe that loss of industry financial support does adversely affect educational and other highly valued activities. They favor greater policy restrictions but do not support an outright ban on pharmaceutical support.
制药行业代表在学术机构进行销售访问或推销活动，已越来越受到批评。作者调查了精神科住院医师和教员对制药行业代表的看法及其与代表的互动情况。
2007 年，作者向西北学术医疗中心的 49 名精神病学教员和 40 名精神科住院医师（住院医生和研究员）发送了一份包含 46 个项目的在线调查，旨在衡量对制药行业代表的态度和互动情况。
完成了 65%（N=58）的调查。三分之二的受访者不同意制药代表具有重要的教学作用。只有 24%的教员和 18%的住院医师同意制药代表提供有关新药的有用和准确信息。41%的教员和 53%的住院医师同意限制制药代表在校园内进行演讲。与教员相比，住院医师不太可能同意如果不分发礼物或食物，他们将与代表保持联系。尽管如此，大多数受访者表示制药公司支持重要会议，超过 90%的人在过去一年中参加了行业赞助的活动。在开放式问题中，受访者表示担心禁令会削弱聘请全国性演讲者的能力，并影响他们重视的其他活动。
教员和精神科住院医师和研究员并不认为制药代表具有重要的教学作用，也不信任他们提供的信息，但他们认为失去行业财政支持确实会对教育和其他高度重视的活动产生不利影响。他们赞成更严格的政策限制，但不支持完全禁止制药业的支持。
